Michael Ferguson
CIK 1607534 · last filed 2025-01-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
16
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENvue Medical, Inc. (NAOV) Delisted | Director | — | $4.02 | — | $0 | 10 | 2025-01-02 |
| Globis Acquisition Corp. (GLAQW) Delisted | Director | 15,000 | $0.43 | $6.5K | $0 | 1 | 2022-01-03 |
| NeuBase Therapeutics, Inc. (OHRP) Delisted | Director | — | — | — | $0 | 2 | 2017-10-18 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-06 | ENvue Medical, Inc. (NAOV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-16 | ENvue Medical, Inc. (NAOV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-18 | NeuBase Therapeutics, Inc. (OHRP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-16 | NeuBase Therapeutics, Inc. (OHRP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-20 | — | Grant (A) | — | $0 | |
| 2015-04-29 | — | Grant (A) | — | $0 |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.